network member

New Mexico

About Network Member

Enrollment Closed

HCRN-GU20-444

Neoadjuvant Pembrolizumab for Muscle-Invasive Bladder Cancer with Selective Bladder Sparing
Cancer areas:Bladder
City of Hope
Icahn School of Medicine at Mount Sinai
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
University of New Mexico Comprehensive Cancer Center